RxDoctor Payments DataLook up a doctor →

Helen Baron, MD

Endocrinology, Diabetes & Metabolism · Rancho Mirage, CANPI 1295762995

Payments from drug & device makers

$957,578in general payments, 2019–2025

Across 730 payments — averaging $1311.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi-aventis U.S. LLC$345K
  • Novo Nordisk$317K
  • Dexcom, Inc.$108K
  • AstraZeneca$86K
  • Abbott$49K
  • Bayer$26K
  • plus $26K from 12 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$957,578 in reported general payments places this provider in the 95th percentile of 952 endocrinology, diabetes & metabolism providers in California.

See all endocrinology, diabetes & metabolism providers in California

Medicare billing

Part B allowed, 2024
$105,644
Medicare patients
462
Services billed
1,355

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Rancho Mirage

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →